The U-M Medical School, the Office of Technology Transfer, and the Office of the Vice President for Research are excited to announce that on February 27 the Michigan Economic Development Corporation awarded $2.4 million to the Medical School to help fund the U-M Michigan Translational Research and Commercialization for Life Sciences Program (U-M MTRAC).
An integral part of the Medical School’s Strategic Research Initiative, U-M MTRAC will provide translational research funding and resources to identify, nurture and “fast forward” projects with a high potential of commercial success. In addition to the MEDC funds, the U-M will provide matching funds of $5.1 million, for a total of $7.5 million over three years.
Over the next three years, UMMS faculty and the region will benefit from U-M MTRAC on many levels. As part of Strategic Research Initiative, projects funded by this program will enhance the internal innovation pipeline for long-term success in commercialization. And while invention reports and IP licensing will be among important milestones, positive impacts to human health – as well as job creation – will be the ultimate measures of success.
Questions? Contact U-M MTRAC Program Director Bradley Martin at 734-936-8577 or email@example.com.
FREQUENTLY ASKED QUESTIONS